United Kingdom· GB-APID-22477111000001104
Methylrosanilinium chloride 2% topical solution
A methylrosanilinium product containing methylrosanilinium chloride, registered in United Kingdom by Special Order. The same ATC class is registered in 2 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Methylrosanilinium is registered in 2 of 19 countries.
Countries holding a registration under ATC D01AE02 (methylrosanilinium), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 1 of them publish a price we can compare per daily dose
Methylrosanilinium · ATC D01AE02
2 / 19 countries
- Norwayprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Methylrosanilinium chloride
- Manufacturer
- Special Order
- Country
- United Kingdom (GB)
- ATC code
- D01AE02
- ATC class
- Methylrosanilinium
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Methylrosanilinium in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDE LA CRUZ GENTIAN VIOLETDLC Laboratories, Inc.
- Poland1% Spirytusowy roztwór fioletu gencjanowego GemiGEMIPHARMA Sp. z o.o.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Poland · 1% Spirytusowy Roztwór Fioletu Gencjanowego, 1% Wodny Roztwór Fioletu Gencjanowego
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f0933d49-eb66-4c6c-83a8-692e59a6f91d GET /v1/drugs/f0933d49-eb66-4c6c-83a8-692e59a6f91d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "22477111000001104",
"desc": "Methylrosanilinium chloride 2% topical solution (Special Order)",
"form": "Cutaneous solution",
"vpid": "22476811000001109",
"source": "dmd",
"vtm_id": "776756001",
"strength": "20 mg",
"substance": "Methylrosanilinium chloride",
"ingredient": "Methylrosanilinium chloride",
"supplier_code": "8286711000001104"
}See everything about methylrosanilinium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.